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Summary The presence or absence of an oestrogen receptor-related antigen in breast tumours has been
examined histochemically using a monoclonal antibody ('D59 - Coffer & King, 1981). In frozen sections, fixed
either by the method of Tamura et al. (1980) or in methanol, staining was apparent in 14/24 (58%) and 22/26
(85%) of the breast cancers respectively. In paraffin sections fixed in ethanol, staining was present in 25/33
breast cancers (76%). In either type of section, staining was predominantly in the cytoplasm of the epithelial
cells. When staining was scored by independent observers (2 or 3) and related to the tumour oestrogen
receptor activity, determined by a standard biochemical technique, antigen was present in both receptor-
positive and receptor-negative tumours. No significant association was found between the presence of antigen
and receptors in the frozen sections, but for the series of paraffin sections, there was a weak association
(r= +0.48) between the presence of the two proteins.
Histochemical processing of paraffin sections from 9 tumours under conditions of higher sensitivity
increased the staining significantly in 2/9 tumours, but did not alter the relationship between staining and
receptor status.
Six tissues were stained after exposure to 'receptor-translocating' conditions (250C/2 nM oestradiol/both
for 1 h): this did not consistently change the subcellular staining pattern, though all tissues tended to stain
more after exposure to 25°C.
Staining was not blocked by absorption of the D, antiserum with a variety of pure proteins or human
serum but at higher concentrations (approx. 2-15 mg protein ml-1), extracts from human uterus, an
oestrogen-receptor-positive breast cancer and an oestrogen-receptor-negative breast cancer all effectively
abolished staining in sections from another breast cancer.
These results are consistent with other reports suggesting that the D5 antibody detects an antigen which is
not the oestrogen receptor, but which may be associated with the receptor in its tissue distribution.
In view of the value of oestrogen receptor measurements in
the management of breast cancer (Hawkins, 1985), much
effort has been expended in attempts to detect the receptor
histochemically by a variety of methods (Lee, 1978;
Pertschuk et al., 1979; Walker, Cove & Howell, 1980). For
the purpose of immunohistochemistry, antibodies of both
polyclonal (Tamura et al., 1984; Lope-Pihie et al., 1985) and
monoclonal type (Greene et al., 1980; Coffer & King, 1981)
have been generated and amongst these, one in particular
(Greene et al., 1980) has been demonstrated to reflect
accurately oestrogen receptor (R) status, in several different
centres (King et al., 1985; Pertschuk et al., 1985; Hawkins et
al., 1986).
In 1981, Coffer and King described two monoclonal
antibodies (D, and C3) which they had raised against
partially purified preparation of the oestrogen receptor
protein from human myometrium. Of these antibodies, D5,
in particular, has been the subject of further studies (Coffer
et al., 1985a,b). In this paper, we report on our own
experience of examining the histochemical staining with the
D5 antibody in a series of breast cancers and relating this to
the biochemically-determined oestrogen receptor contents of
the same tissues.
Materials and methods
Chemicals and radiochemicals
[2,4,6,73H] oestradiol-17,B (Sp Act 92 Cimmol 1) was
obtained from Amersham International, Bucks, UK, and
was purified at approximately monthly intervals by
chromatography on Sephadex LH-20. The latter and
Dextran T-70 were obtained from Pharmacia Ltd, London,
while most other reagents were obtained from either the
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Sigma Chemical Company, London, (monothioglycerol,
bovine serum albumin, ovalbumin, Norit A, insulin) or BDH
Ltd, Poole, Dorset, (solvents, tris, sucrose, hydrogen
peroxide, diaminobenzidine and inorganic chemicals).
Scintol-7 was purchased from Koch-Light Ltd, Haverhill,
Suffolk, and diluted (100ml) with analytical grade toluene
(2450ml) containing ethanol (2% v/v) from BDH.
Breast tumours and other tissues
Benign or malignant breast tissues were collected at biopsy
or mastectomy, and transported on ice to the Department of
Pathology and then to the receptor assay laboratory. After
removal of a slice of tumour for fixation in formol-saline
and routine histology, and a second portion (>300mg) for
oestrogen receptor assay, the remainder was used for histo-
chemical staining. For 57 specimens, (50 breast cancers, 5
benign breast lesions and the uteri from a mature rat and
from a woman), the tissue was frozen.in liquid nitrogen until
use for frozen sections (series A). For a further 41 samples
of breast tissue, the specimen was fixed in ethanol prior to
setting in paraffin blocks (series B).
A further 6 breast tumours were used for 'translocation
studies' (series C) and another tissue was used for studies on
the specificity of the staining (series D). For the latter
experiments, five additional tissues (human uterus,
lymphoma, melanoma, bronchial carcinoma and a sample of
normal human blood) were also collected and used to
prepare tissue extracts or serum.
The details for each series of tissues are given below.
Frozen sections - series A
A total of 57 tissues was used to cut frozen sections in two
sub-series (I and II).
In an initial sub-series (I) of 26 selected tissues (24 breast
tissues, 1 human uterus and 1 rat uterus), tissues were cut
and processed according to the method of Raam's group
(Tamura et al., 1984). In brief, the tissue blocks were
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embedded in gelatin, frozen and cut to yield 4ym frozen
sections. The sections were air-dried for 20min, dipped
quickly in saline and dehydrated in a series of alcoholic
salines (30, 50, 75, 90 and 100% v/v) and xylene, being
exposed to each fluid twice, for 5min per dish. The sections
were then rehydrated stepwise by exposure to these fluids in
the reverse order and washed 3-4 times in saline prior to
histochemical assay.
In a second sub-series (II) of 31 breast tissues, the stored
tumour from liquid N2 was frozen directly on the chuck,
using OCT as a support, and 4pm sections were cut. These
were fixed by immersion in methanol (100% v/v) for 20min.
Paraffin sections - series B
A total of 41 tissues was used in two sub-series (I and II). In
both a preliminary series (I) of 8 tissues and a later series
(II) of 33 tissues, the tissue was fixed in ethanol (100% v/v)
at room temperature for 3 h and cleared in xylene prior to
setting in paraffin blocks for cutting and staining of paraffin
sections.
Translocation studies - series C
A total of 6 breast cancers were cut into slices
(approximately 2 x 2 x 0.5cm) and incubated in Tris-buffered
saline (TBS) under conditions previously reported (Jensen &
De Sombre, 1973) to 'translocate the oestrogen receptor
from cytoplasm to nucleus'.
For each of the 6 tissues, slices were incubated (a) for 1 h
at 25°C in the presence of 2 nM oestradiol-17f, (b) for 1 h
at 25°C in TBS only and (c) for 1 h at 4°C in 2 nM
oestradiol-17p, prior to freezing of the slices in liquid
nitrogen. The slices were later used to cut frozen sections
(4 tm) which were processed histochemically as described
below.
Specifity studies - series D
One tissue (biochemically receptor-positive and positive for
histochemical staining) was fixed in alcohol and embedded in
paraffin. Sections (4 tm) were cut and assayed histo-
chemically using the conditions described below except that
the first antibody (Ab,) was used with or without exposure
to potential 'blocking agents' for h at 4°C: these were
(a) pure proteins (human serum albumin, insulin, ovalbumin,
gelatin, prolactin, transferrin, human y-globulin), (b)
'cytosols', prepared as described previously (Hawkins et al.,
1981) from a variety of tissues (R+ve and R-ve breast
cancers, human uterus, lymphoma, melanoma, invaded nodal
metastasis of a bronchial carcinoma), or (c) normal human
serum.
Histochemical assay
In general, four or more sections (4gm) were cut from each
tissue: one was stained with haematoxylin and eosin
('H +E'), another was exposed only to the peroxidase
reagents ('endogenous peroxidase'), the third was exposed
only to the second antibody ('control') and the fourth to
both first and second antibodies ('test').
In early experiments, (series A-I, B-I), sections were
successively treated with normal rabbit serum (1:4
v/v='NRS') for 10min, D5 antibody (Abl=1:60 in NRS)
either, for 45min at 30°C or overnight at 4°C, PBS twice for
5min, NRS for 10min, peroxidase-conjugated, rabbit anti-
mouse IgG ('Ab2' from Myles Laboratories, 1:20 in NRS
containing normal human serum, NHS 1:25) for 45min at
either 30°C or 37°C, and PBS twice for 5min The sections
were then stained with Hanks-Yates Reagent (24mg in 30ml
0.1 M Tris buffer, pH 7.6, mixed with 100 1 3% v/v H202)
for 10min, washed in running water for 5min, dehydrated,
cleared in xylene and mounted in DPX.
In later experiments (series A-TI, B-IT, C and D), frozen
sections, fixed in methanol, or paraffin sections, were treated
with normal rabbit serum (1:5 v/v='NRS') for 10min, D5
antibody (Ab1 =1:60 in NRS) for 30min at room
temperature, PBS twice for 5min, peroxidase-conjugated,
rabbit anti-mouse IgG ('Ab2' from DAKO PATTS,
Denmark, 1:20 in NRS) for 30min at room temperature,
and PBS twice for 5min. The sections were stained with
DAB (1 mgml-l in Tris-HCL pH 7.6) and H202 (0.05%
v/v) in the presence (A-IT series) or absence (B-IT series) of
imidazole (0.01 nM) for 5min, washed in running tapwater
for 5min, dehydrated, cleared and mounted as above.
In 9 selected tissues, paraffin sections were reassayed at
'greater sensitivity' i.e. the sections were incubated with Ab,
overnight at 4°C, with Ab2 for 30min at room temperature
and stained with DAB-H202 in the presence of imidazole.
Once stained, specimens were examined microscopically
and scored independently by 2 or 3 observers for the degree
of staining on an arbitrary scale of 0, 1, 2 or 3+. 'Staining
intensity' was then found by subtracting the average staining
in the control (No Ab,) section (usually little) from that seen
in the test section. Assessment differed slightly in the series
of tissues examined, due to increasing experience: in the
frozen sections (series A-I and A-IT), an average staining
intensity was given for the whole epithelial cell population,
but in the paraffin sections (series B-II), first the proportion
of epithelial cells staining (%) was gauged and then that
subpopulation of cells was given a score for stain intensity.
Although the latter procedure is more accurate, it does not
alter the overall assessment.
Finally, from the haematoxylin and eosin-stained section,
an estimate was made of the proportion of the whole tissue
specimen which was occupied by epithelial cells ('cellularity').
Biochemical determination ofoestrogen receptor activity
A portion of tissue (>300mg) was homogenised in tris
buffer (tris 10mM, sucrose 0.25 M, EDTA 1 mM, pH 8.0)
containing 10% (v/v) glycerol and 1% (v/v) monothio-
glycerol, the homogenate was centrifuged at 2040g and the
resulting, supernatant tissue extract was used for the assay of
oestrogen receptor activity as described previously (Hawkins
et al., 1981). By Scatchard (1949) analysis of the resulting
data, the dissocation constant of binding (Kd) and receptor
site concentration were calculated.
Soluble protein concentration was measured by the dye-
binding method of Bradford (1976) and receptor concen-
tration was expressed as fmol binding sites mg-1 protein.
Tissues containing <5fmol sites mg-' protein were classed
as receptor-negative.
Results
Histochemical staining infrozen sections (series A)
In a preliminary study (A-I), 26 tissues selected as either
highly R+ or R- were cut, fixed, mounted and stained
according to Tamura et al. (1984). Weak cytoplasmic
staining of neoplastic epithelial cells was seen in 14 of the 24
breast tissues (58%). Some cases showed staining of a small
number of stromal cells.
Sections of human myometrium also showed cytoplasmic
staining, but whilst rat uterus showed some staining in the
control (no Ab,) section, there was little additional staining
in the test section. The results are summarised in relation to
biochemical receptor status in Table I and Figure 1. There it
can be seen that some 60% of the receptor-negative breast
tumours failed to stain significantly (intensity >0.5) whilst
73% of the receptor-positive tumours showed staining. There
was no significant correlation between staining and receptor
content.
Since the above method demonstrated only weak staining,
a second series (A-IT) of 31 tissues was examined using a
shorter method involving fixation in methanol and staining
with DAB in the presence of imidazole. This gave moreOESTROGEN RECEPTOR-RELATED ANTIGEN IN BREAST CANCER 613
Table I Histochemical staining in frozen sections
of 24 breast tissues of known receptor status using
antibody D5 (fixation according to Tamura et al.,
1984)
Receptor status Proportion staininga %
R-rich 10/14 70%
(>98)b
R-negative 4/10 40%
(<5)
aProportion of tissues showing significant
staining, i.e. >score of 0.5 on a scale 0-3.
bReceptor concentrations determined bio-
chemically in fmol mg-1 protein.
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Figure 1 The relationship between histochemical staining with
D5 antibody in frozen sections from 24 selected breast cancers
and oestrogen receptor concentration, determined by a standard
biochemical method. Tissues were selected on the basis of the
receptor assay result (either R- or high R+) and flxed
according to Tamura et al. (1984). Staining intensity represents
the mean of assessments by 2 independent observers, on an
arbitrary scale of 0 to 3 +.
intense and more easily identifiable cytoplasmic staining of
the epithelium. Of the five benign breast tissues examined, 2
(i.e. 20%) showed significant staining whilst 22 or the 26
breast cancers (85%) exhibited staining. The relationship
between the histochemical staining intensity in these tissues
and the biochemical receptor content is shown in Figure 2.
Again there was no correlation between either staining
intensity (Figure 2) or a cellularity-corrected staining
intensity (intensity x 100/% cellularity, not shown) and
receptor content (by Spearman's Rank Test, = -0.24,
P<0.1 and +0.06, P>0.1 respectively).
Histochemical staining in paraffin sections (series B)
In a preliminary series of experiments (B-I), eight breast
cancers were fixed in ethanol, embedded in paraffin, cut,
incubated and stained with Hanks-Yates reagent. None of
these tissues exhibited any staining, possibly due to
contamination of the paraffin wax used with formol-saline.
In a second series of tissues (B-II), 33 tissues were
similarly processed but stained with DAB in the absence of
imidazole. In these tissues, histochemical staining was
present in 25/33 (76%), and oestrogen receptors in 25/33
(76%) also. Staining was again predominantly found in
epithelial cell cytoplasm but, in addition, a rim of surface
membrane staining could be seen in many of the tumour
cells. In some cases, there was noted considerable hetero-
geneity of staining intensity between different areas of
Figure 2 The relationship between histochemical staining with
Ds antibody in frozen sections from 26 unselected breast cancers
and oestrogen receptor concentration, determined by a standard
biochemical method. Tissues were fixed in methanol. Staining
intensity represents the mean of assessments by 3 independent
observers on an arbitrary scale of 0 to 3+. Correlation
coefficient (Spearman) r= -0.24.
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Figure 3 The correlation between histochemical staining with
D5 antibody in paraffln sections from 33 breast cancers and
oestrogen receptor concentration, determined by a standard
biochemical method. Tissues were fixed in ethanol. Staining
intensity represents the mean of assessments by 3 independent
observers on an arbitrary scale of 0 to 3 +. Correlation
coefficient (Spearman) r= +0.41.
tumour. Occasional stromal cells also showed cytoplasmic
staining.
The presence of receptors was correlated with staining
intensity (Figure 3, Spearman's Rank Test z = +0.41) or a
histochemical staining index, (=intensity x 100/% cells
stained x 100/% cellularity as previously defined - Hawkins
et al., 1986; Figure 4, Spearman's z = +0.48). There were,
however, tissues with no receptor activity which stained
strongly, and conversely, tissues with high activity which
stained only weakly.
Of these tissues, nine (with receptor activities ranging from
6-475fmol sites mg-1 protein) were reassayed histo-
chemically under conditions selected to stain more intensely
(overnight binding of first, D5 antibody, plus inclusion of
imidazole in the staining reagent). Under these conditions,
the control (no first antibody) sections were stained slightly
more intensely, and though there was some increase in both
intensity and percentage of cells staining of the test sections,
with two exceptions (JF and MB), the overall pattern of
staining was not significantly altered (Table II).
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'Translocation' studies (series C)
A series of 6 tissues were stained under 'translocating' and
'non-translocating' conditions. The results are shown in
Table III. Staining, in general, was localised mainly in the
epithelial cell cytoplasm but was also present in some
stromal cells. All six tissues showed a tendency for greater
staining, particularly of stromal cells, after exposure to 25°C.
There was no clear relationship between staining and
oestrogen receptor concentration. There was no consistent
trend for increasing nuclear staining with increasing
temperature or presence of oestrogen.
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Figure 4 The correlation between histochemical staining with
D5 antibody, corrected for the proportion of specimen not
staining, and oestrogen receptor concentration in 33 breast
cancers. Tissues were fixed in ethanol and embedded in paraffin.
'Staining Index'=staining intensity x fraction of tissue occupied
by cells x fraction of cells staining. Correlation coefficient
(Spearman) r= +0.48.
Table II Re-examination of selected tissues for histochemical
staining at higher sensitivity
Histochemical staining
Oestrogen receptors
Patient (fmolmg-1 protein) Assay 1 Assay 2
AK 6 6%++ 10%+++
JF 6 5%+ + 95%+
MB 24 5% + 95% + + +
EO 28 0 25% + +
BMc 34 60%+ 99%+ +
MW 83 60%+ + 95% + + +
AB 185 10%+/- 62%+
IB 228 77%+ + 97%+ + +
EMc 475 17%+ 40%+ +
Nine selected specimens were assayed initially by incubating
with D5 antibody (Ab1) for 30min at room temperature and
eventually stained in DAB-H202 (Assay-l). In a second assay,
incubation with Ab1 was continued overnight, and sections were
stained with DAB-H202 in the presence of imidazole (Assay-2).
Scores represent the mean of observations by 2 independent
observers for the % cells staining and the intensity of staining on
a scale of - to + + + (i.e. 0 to 3.0+).
Specificity studies (series D)
In initial experiments on the specificity of staining with D5
antibody, the antiserum was absorbed by inclusion of either
pure protein (2mgml-1), or cytosol (prepared by
homogenising 100mg tissue in 1 ml buffer and centrifuging)
prior to use. The results, demonstrate that no blocking of
staining in a D5-positive, R-positive breast cancer was
observed with the pure proteins (Table IV) but that a little
blocking was seen with the cytosols from uterus and two of
the breast cancers (Table V).
In a second experiment, staining in the same tissue was
examined after exposure of sections to the antibody (1/30) in
varying dilutions (25%-98% v/v) of cytosol (from tissue
homogenised at the rate of 200mgml-1) or normal human
Table IV Specificity of staining: effect of 'absorption' of D5
antiserum with various proteins on histochemical staining in an
oestrogen-receptor positive breast cancera
Proteinb Staining intensityc Blockingd
None (control) 2.5 0
Gelatin 3.0 -0.5
Human IgG 3.0 -0.5
Human serum albumin 2.75 -0.25
Insulin 3.0 -0.5
Ovalbumin 2.5 0
Prolactin 2.5 0
Transferrin 3.0 -0.5
aThe tumour contained 490fmol oestrogen receptor sites by
routine biochemical assay.
bProtein solutions, strength 2mgmlP, were mixed 1:1 (v/v) with
Ab1 1/30 (D.) to give a final Ab1 dilution of 1/60 and left 1 h at
4°C before use.
cStaining intensity represents the means of the scores by two
observers, on a scale of0 to 3.0+.
d"Blocking' is the decrease in staining intensity from that seen in
the unabsorbed control (=2.5).
Table III Histochemical staining with D5 antibody under 'translocating'
conditions
Staining intensity
Oestrogen receptors
Patient (fmolmg I protein) 4° (2nmot) 25° (2nmol) 25° (Tris)
AP 0 0.2 0.75 0.75
(S) (C) (S)
GB 6 1.2 2.0 2.0
(N) (N) (N)
EJ 38 1.5 1.5 2.0
(C+N) (C+N) (C+N)
MS 65 0.2 2.5 1.5
(S) (S+N) (S)
MB 748 2.0 2.0 3.0
(S+C) (S,N+C) (S,N+C)
AR 756 0.5 2.5 2.5
(S+N) (S+C) (S+C)
Staining represents the mean of intensity of staining, assessed by two
observers on a scale of 0 to 3.0+. Staining was located mainly in the stroma
(S), or epithelial cell cytoplasm (C) and occasionally in the epithelial cell nuclei
(N).
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Table V Specificity of staining: effect of absorption of D.
antiserum with cytosols from various tissues on histochemical
staining in an oestrogen receptor-positive breast cancer'
Tissue cytosolb Staining intensityc Blocking
None (control) 3.0 0
Human uterus 2.25 0.75
Lymphoma 3.0 0
Melanoma 2.75 0.25
Bronchial cancer 3.0 0
R-breast cancer 2.25 0.75
R+breast cancer1 2.25 0.75
R+breast cancer2 3.0 0
aThe tumour for staining contained 490fmol oestrogen receptor
sites mg-1 protein by routine biochemical assay. The breast cancers
(1 and 2) uterus and lymphoma, used to generate cytosols contained
238, 150, and 100 and 5fmol receptor mg-' protein respectively.
Protein concentrations for the cytosols were 4.26 (uterus), 7.39
(lymphoma), 6.80 (melanoma), 4.85 (bronchial carcinoma), 4.68
(R-breast cancer), 4.55 and 2.39 (R+breast cancers) mgmlP-.
'Cytosols, prepared by homogenising 200mg tissue in 2ml buffer
and low speed centrifugation, were mixed (v/v) with Ab1 1/30 to
give a final dilution of 1/60 and left 1 h at 40C before use.
cStaining intensity represents the means of scores by two
observers, on a scale from 0 to 3.0+. 'Blocking' represents the
diminution in staining from the control value (=3.0).
Table VI Specificity of staining: effect of absorption of D5
antiserum with varying concentrations of cytosols and serum on
histochemical staining in an oestrogen receptor-positive breast
cancer'
Staining
Serum/cytosol" Concentration intensityc Blocking
None (control) 0 2.75 0
Human serum 25% 2.5 0.25
50% 2.0 0.75
75% 2.25 0.5
98% 2.25 0.5
R-breast cancer 25% 2.5 0.25
50% 1.0 1.75
75% 0.5 2.25
98% 0.5 2.25
R+breast cancer 25%
50% 1.25 1.5
75% 0.5 2.25
98% 0.5 2.25
Human uterus 25% 3.0 -0.25
50% 1.75 1.0
75% 0.13 2.62
98% 0.13 2.62
aThe tumour for staining contained 490fmol receptor sites mg-'
protein; the R+breast cancer and uterus used for blocking
contained 238 and 100fmol receptors mg-1 protein respectively.
Protein concentrations in the cytosols were R+ cancer
6.22mgml -1, R- cancer 15.32mgml -1 and uterus 3.65mgml -1.
bCytosols (fmol 400mg tissue/2ml buffer) or normal human
serum, at the final concentration shown, were used to dilute Ab1
(D5) to 1/60 (v/v).
cStaining intensity represents the means of scores by two observers
on a scale from 0 to 3.0+. 'Blocking' represents the diminution in
staining from the control value (= 2.75).
serum (Table VI). Whilst no consistent effect was seen with
the latter, cytosolic extracts from both R+ and R - breast
cancers significantly inhibited staining and with cytosol from
a human uterus, the blocking was virtually complete.
Discussion
Some 58-85% of the breast cancers examined in this study
exhibited significant staining with D. antibody, a range of
figures similar to the reported incidence of oestrogen
receptor activity (Hawkins et al., 1980).
This antibody was generated against a purified preparation
of oestrogen receptor from the human myometrium and at
the outset of these studies, we did not know whether or not
the antibody detected the classical oestrogen receptor.
Preliminary studies (Coffer et al., 1985a,b; King et al., 1984)
had demonstrated an association between receptor positivity
and reactivity with D5. The object of our studies was
therefore to examine the relationship between staining with
D5 and receptor activity, as determined by our routine
biochemical assay, established some 13 years ago.
In a preliminary study (A-I), frozen sections from tissues
of very clearly defined oestrogen receptor status were
processed by a procedure based on that of Raam's group
(Tamura et al., 1984). No significant relationship between
receptor activity and staining was apparent. Since, however,
the fixation procedure employed was rather long, we decided
to repeat such a study but using a simpler fixation procedure
on tissues of unselected receptor status (A-II); again no
correlation between staining and receptors was found in the
frozen sections. As the initial studies by King and his
colleagues had demonstrated a relationship between D5
staining and oestrogen receptor activity in paraffin-fixed
sections, a third series of unselected tissues (B) were fixed in
ethanol and embedded in paraffin. In this third series of
tissues, we were able to confirm the existence of an
association between D5 staining and oestrogen receptor
activity, though the correlation was weak (r= +0.40 to
+0.48) and again, several receptor-negative tissues stained
quite strongly.
These findings are in line with what has subsequently
become known about the antigen against which D. was
raised. This antigen differs from the native oestrogen
receptor in several respects (Coffer et al., 1985a,b; King et
al., 1985), notably in having a molecular weight of 29,000-
36,000 (cf. the oestrogen receptor- 66,182 - Green et al.,
1986). Although in other histochemical studies (King et al.,
1984; King et al., 1985; Cano et al., 1986) and immunoradio-
metric assay (Coffer et al., 1985a), receptor activity and the
presence of antigen were strongly correlated, in our hands,
the correlation between staining and receptor content is
modest, a view supported by the immunoassay findings of
some other laboratories (Colin et al., 1985; Leake & Cowan
- personal communication). It is thus appropriate that the
D5 antigen has now been designated 'oestrogen receptor-
associated'.
The precise function and identity of the D5 antigen are, as
yet, uncertain and being investigated. It is already clear,
however, that for the purpose of measuring oestrogen
receptor concentration directly, other antibodies and assays
(i.e. these developed by Green, Jensen and colleagues in
Chicago - King et al., 1985) are proving accurate and
adequate. The value of the D5 antigen and its detection,
therefore, lies in the fact that it is not identical with the
oestrogen receptor (cf. King et al., 1985) but is a different
molecule, which may reflect a different facet of endocrine
sensitivity, with its own prognostic/predictive significance
which may be independent of, and/or additive to, that of
oestrogen receptor activity.
We thank Drs R.J.B. King and A. Coffer for providing the D.
antibody and for helpful advice and discussion, and Miss A. Tesdale
and Mr W.A. Ferguson who performed the routine biochemical
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